Long Term Durability and Safety of Dual IO in NSCLC

G

Neoadjuvant Chemotherapy and Immunotherapy for NSCLC

By Giuseppe Banna
133 views
November 11, 2022
0 Comments
Login to view comments. Click here to Login
09:22

2021 ASCO Review on Nivo + Ipi vs. Chemo as 1L Treatment for Advance…

Luis Paz-Ares

609 views
09:18

1L Nivo + Ipi + 2 Cycles of Chemo vs. Chemo Alone (4 Cycles) in mNSC…

Filippo de Marinis

494 views
11:11

2021 ASCO Update on 1L Nivo + Ipi + 2 Cycles of Chemo vs. Chemo Alon…

Tom John

427 views
04:06

1L Nivo+Ipi+Chemo for Patients With Advanced NSCLC and Brain Mets: R…

ecancer

D. Carbone

655 views
05:22

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

ecancer

S. Peters

362 views
07:25

ASCO 2021 Update on IO in NSCLC: Considering Data From the Key Trials

ecancer

L. Raez

69 views
31:18

2021 ASCO Updates on Lung Cancer: (Neo)adjuvant Therapy, Metastatic …

UAB Medicine Hematology and Oncology Highlights 2021

A. Hegde

102 views
19:26

Standard 1L Treatment of Advanced NSCLC in 2021: IO Combination & Mo…

Mariam Alexander

629 views
20:10

Epidemiological Shifts in Lung Cancers: Trends in Treatment and Diag…

Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

E. David

162 views
14:53

Serum Proteomic Signature & Advanced NSCLC: Can It Be Used as an Out…

Northwestern Medicine Oncology and Hematology

Y. Chae

417 views
36:33

Neoadjuvant Treatment of NSCLC With Immune CPIs: Biological Understa…

CECOG Academy

C. Zielinski

194 views
17:55

USC Updates on RT for mNSCLC: Consolidative Local Therapy

Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

M. Daly

87 views
21:04

Metastatic NSCLC: Approaches and Updates

2022 West Oncology Conference

J. Porter

1.1K views
07:37

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

277 views
24

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

19 views
01:18

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

87 views
13:01

ASCO 2022 on Immunotherapy Updates in Advanced NSCLC

Nebraska Oncology Society

J. Brahmer

1.9K views
09:18

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

476 views
01:46

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

20 views
06:03

Penn Medicine mNSCLC Updates

Penn Medicine Abramson Cancer Center

M. Marmarelis

99 views
10:59

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

145 views
01:24

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

96 views
16:37

ASCO 2022 Early Stage NSCLC Updates

Lung Cancer Europe (LuCE)

J. Naidoo

338 views
47:32

1L Therapy for Advanced/Metastatic PD-L1 Negative (TPS <1%) NSCLC

Aaron Franke

576 views
10:17

WCLC 2022 on Modifiable Biomarkers of Response to Immune Checkpoint …

WCLC 2022 Conference Coverage

D. Spakowicz

159 views
01:43

Lecture Summary - WCLC 2022 on Modifiable Biomarkers of Response to …

WCLC 2022 Conference Coverage

D. Spakowicz

7 views
17:29

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Perspective

ILCC 2022 Conference Coverage

T. Mitsudomi

1.1K views
07:36

ESMO 2022 on the CheckMate 9LA Study Results: Clinical Outcomes in P…

ESMO 2022 Conference Coverage

T. John

259 views
08:17

Neoadjuvant Nivo + Platinum-Doublet Chemo vs. Chemo for Resectable (…

Nicolas Girard

92 views